European Data Protection Board Adopted New Guidelines Regarding COVID-19 Outbreak
European Data Protection Board Adopted New Guidelines Regarding COVID-19 Outbreak
European Data Protection Board Adopted New Guidelines Regarding COVID-19 Outbreak
As per the new announcement published by the Turkish Medicines And Medical Devices Agency (“the Agency”), the previously published announcements on the pre-authorization application processes regarding the certain export prohibited products have been updated and as of April 27, 2020, the applications to be made to the Agency shall continue in accordance with the new guide attached to the announcement.
To respond the struggles experienced by the businesses in terms of contractual liabilities in the wake of COVID-19, International Chambers of Commerce (“ICC”) has updated the 2003 version of its force majeure and hardship clauses. With the recent update dated March 25, 2020, ICC aimed at bringing an equivalence for the parties’ legitimate expectations of performance that impinged due to COVID-19 outbreak.
Second medical use claims provide the required protection for originator companies to recoup research investments in therapeutic use based on the original chemical compound. The claim provides additional 20 years protection after the expiry of the original patents that provide product protection for the medical substance.
As the COVID-19 outbreak continues to affect daily life, the use of technology in training schemes have become more popular than ever. Currently, people all around the world are seeking alternative training methods that allow them to sustain regular training schedules.
Today, the Covid-19 outbreak has required large volume of process in a short period of time for both companies and individuals. Unfortunately, not by choice, some of the legacies are left behind. As a result of the overall embraced isolation approach, individuals are avoiding the public places, and most of the stores are shut down except the ones required for essential needs.
Turkish Competition Authority (“Authority”) on April 17, 2020 published an announcement regarding the extension of the deadlines for inquisitions, researches and investigations carried out during the Covid-19 pandemic under the Law on the Protection of Competition (“Law No. 4054”) in order to not to cause any detriment to respective parties’ rights.
The race for finding a cure for COVID-19 continues, as more research centers, private enterprises and universities around the globe concentrate on finding an antiviral or vaccine against the virus or providing new solutions for medical equipment manufacturing.
Due to the COVID-19 outbreak and its significant impacts in our daily lives, extremely intrusive data processing activities have been negotiated and taken into place by governments, public institutions, and organizations. In this respect, due to the measures taken in order to mitigate the risk regarding pandemic, many governments have decided to use geolocation tools to determine possibly infected ones by checking the routes that have been used by infected people.
As a precaution against the rapid spread of the global pandemic, many of the companies switched to remote working strategies and started to apply social distance rules to mitigate the effect of the Covid-19. With the increase in the number of people working remotely, companies and organizations will undoubtedly have to think about how to execute documents and contracts, along with the measures taken against the Covid-19.
Turkish Personal Data Protection Board (“Board”) released its recent rulings in summary regarding the application of the Law on the Protection of Personal Data No. 6698 (“Law No. 6698”) on April 15, 2020. In this information note, you will be provided extracts of these two summaries.
As per the Law on Mitigating the Effects of the New Coronavirus (Covid-19) Outbreak on Economic and Social Life and the Law Amending Certain Laws published in the Official Gazette numbered 31102 on April 17, 2020; a new provisional article was added to Turkish Commercial Code numbered 6102 (“TCC”) highlighting the economic impacts of Covid-19 on the company resources.